FACTANKER

LIPOCINE INC. — Operating Income by Fiscal Year

14 fiscal years, as filed with the SEC; every row links its evidence fact.

Fiscal yearOperating IncomePeriodEvidence
FY 2025$-10.4M2025-01-01 – 2025-12-31evidence 0001493152-26-009411
FY 2024$-1.2M2024-01-01 – 2024-12-31evidence 0001493152-25-010146
FY 2023$-17.9M2023-01-01 – 2023-12-31evidence 0001493152-24-009127
FY 2022$-12.1M2022-01-01 – 2022-12-31evidence 0001493152-23-007178
FY 2021$3.1M2021-01-01 – 2021-12-31evidence 0001493152-22-006353
FY 2020$-18.0M2020-01-01 – 2020-12-31evidence 0001104659-21-034761
FY 2019$-12.9M2019-01-01 – 2019-12-31evidence 0001104659-20-032764
FY 2018$-11.3M2018-01-01 – 2018-12-31evidence 0001144204-19-012434
FY 2017$-21.2M2017-01-01 – 2017-12-31evidence 0001144204-18-013981
FY 2016$-19.2M2016-01-01 – 2016-12-31evidence 0001144204-17-012930
FY 2015$-18.4M2015-01-01 – 2015-12-31evidence 0001144204-16-087232
FY 2014$-20.5M2014-01-01 – 2014-12-31evidence 0001144204-15-015256
FY 2013$-10.7M2013-01-01 – 2013-12-31evidence 0001144204-14-019291
FY 2012$3.9M2012-01-01 – 2012-12-31evidence 0001144204-14-019291
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

LIPOCINE INC. — all facts · Revenue · Net Income · Cite as: FACTANKER, https://factanker.com/entity/052e281f-32c8-41aa-a3af-e96a6eed077e/serie/operating-income